News
Podcast: Talking the cure
11 April 2024
Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...
News
11 April 2024
Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...
News
15 March 2024
Join us as we embark on a journey towards a more regulated and ethically conscious era of artificial intelligence. In this six-part video series, 2024 – The year of AI, our Global...
News
10 November 2023
We are at the forefront of understanding and managing the risks and opportunities of artificial intelligence, and ahead of the UK’s first global AI Safety Summit, hosted by the UK...
News
30 October 2023
We are at the forefront of understanding and managing the risks and opportunities of artificial intelligence, and ahead of the UK’s first global AI Safety Summit, hosted by the UK...
News
27 July 2023
A cross-practice Global Regulatory & IPMT team hosted a roundtable discussion on the key requirements that industry would like to see incorporated in the UK Government’s approach...
News
29 June 2022
Following its first consultation on artificial intelligence and intellectual property in 2020, the UK Intellectual Property Office launched a second consultation in October 2021. This...
News
15 June 2022
At our recent Health Care AI Law and Policy Summit, Hogan Lovells attorneys Dan Whitehead, Bonella Ramsay, Louise Crawford, and Imogen Ireland convened with industry leaders virtually at...
News
05 January 2022
At the end of October 2021, the UK Intellectual Property Office launched its second consultation on artificial intelligence. The consultation is seeking evidence and views on the extent to...
News
08 December 2020
In recent years, AI has become a buzzword in life sciences and health care as the technology has developed to create applications from drug discovery to diagnostics to therapeutics. Most...